Chemical Compound Review:
Tafenoquine N-[2,6-dimethoxy-4-methyl-5- [3...
Synonyms:
CHEMBL298470, SureCN347388, AC1L3GZN, LS-172012, WR-238605, ...
Walsh,
Wilairatana,
Tang,
Heppner,
Brewer,
Krudsood,
Silachamroon,
Phumratanaprapin,
Siriyanonda,
Looareesuwan,
Brueckner,
Coster,
Wesche,
Shmuklarsky,
Schuster,
Tekwani,
Walker,
Edstein,
Kocisko,
Brewer,
Walsh,
Eamsila,
Charles,
Walsh,
Eamsila,
Sasiprapha,
Sangkharomya,
Khaewsathien,
Supakalin,
Tang,
Jarasrumgsichol,
Cherdchu,
Edstein,
Rieckmann,
Brewer,
Walsh,
Looareesuwan,
Wilairatana,
Heppner,
Tang,
Brewer,
Chokejindachai,
Viriyavejakul,
Kyle,
Milhous,
Schuster,
Horton,
Braitman,
Brueckner,
Shanks,
Edstein,
Puri,
Dutta,
Edstein,
Walsh,
Eamsila,
Sasiprapha,
Nasveld,
Kitchener,
Rieckmann,
- Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. Walsh, D.S., Looareesuwan, S., Wilairatana, P., Heppner, D.G., Tang, D.B., Brewer, T.G., Chokejindachai, W., Viriyavejakul, P., Kyle, D.E., Milhous, W.K., Schuster, B.G., Horton, J., Braitman, D.J., Brueckner, R.P. J. Infect. Dis. (1999)
- Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial. Brueckner, R.P., Coster, T., Wesche, D.L., Shmuklarsky, M., Schuster, B.G. Antimicrob. Agents Chemother. (1998)
- Sporontocidal activity of the antimalarial WR-238605 against Plasmodium berghei ANKA in Anopheles stephensi. Coleman, R.E. Am. J. Trop. Med. Hyg. (1990)
- WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeys. Obaldia, N., Rossan, R.N., Cooper, R.D., Kyle, D.E., Nuzum, E.O., Rieckmann, K.H., Shanks, G.D. Am. J. Trop. Med. Hyg. (1997)
- Blood schizontocidal activity of WR 238605 (Tafenoquine) against Plasmodium cynomolgi and Plasmodium fragile infections in rhesus monkeys. Puri, S.K., Dutta, G.P. Acta Trop. (2003)
- Modern malaria chemoprophylaxis. Shanks, G.D., Edstein, M.D. Drugs (2005)
- Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria. Walsh, D.S., Eamsila, C., Sasiprapha, T., Sangkharomya, S., Khaewsathien, P., Supakalin, P., Tang, D.B., Jarasrumgsichol, P., Cherdchu, C., Edstein, M.D., Rieckmann, K.H., Brewer, T.G. J. Infect. Dis. (2004)
- 8-Aminoquinolines from Walter Reed Army Institute for Research for treatment and prophylaxis of Pneumocystis pneumonia in rat models. Bartlett, M.S., Queener, S.F., Tidwell, R.R., Milhous, W.K., Berman, J.D., Ellis, W.Y., Smith, J.W. Antimicrob. Agents Chemother. (1991)
- Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force. Edstein, M.D., Walsh, D.S., Eamsila, C., Sasiprapha, T., Nasveld, P.E., Kitchener, S., Rieckmann, K.H. Médecine tropicale : revue du Corps de santé colonial. (2001)
- 8-Aminoquinolines: future role as antiprotozoal drugs. Tekwani, B.L., Walker, L.A. Curr. Opin. Infect. Dis. (2006)
- First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. Brueckner, R.P., Lasseter, K.C., Lin, E.T., Schuster, B.G. Am. J. Trop. Med. Hyg. (1998)
- Metabolism of a candidate 8-aminoquinoline antimalarial agent, WR 238605, by rat liver microsomes. Idowu, O.R., Peggins, J.O., Brewer, T.G., Kelley, C. Drug Metab. Dispos. (1995)
- In vitro activity of tafenoquine alone and in combination with artemisinin against Plasmodium falciparum. Ramharter, M., Noedl, H., Thimasarn, K., Wiedermann, G., Wernsdorfer, G., Wernsdorfer, W.H. Am. J. Trop. Med. Hyg. (2002)
- Gametocytocidal and sporontocidal activity of antimalarials against Plasmodium berghei ANKA in ICR Mice and Anopheles stephensi mosquitoes. Coleman, R.E., Clavin, A.M., Milhous, W.K. Am. J. Trop. Med. Hyg. (1992)
- Simultaneous modeling of the pharmacokinetics and methemoglobin pharmacodynamics of an 8-aminoquinoline candidate antimalarial (WR 238605). Brueckner, R.P., Fleckenstein, L. Pharm. Res. (1991)
- Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse. Walsh, D.S., Wilairatana, P., Tang, D.B., Heppner, D.G., Brewer, T.G., Krudsood, S., Silachamroon, U., Phumratanaprapin, W., Siriyanonda, D., Looareesuwan, S. Clin. Infect. Dis. (2004)
- Malaria chemoprophylaxis with tafenoquine: a randomised study. Lell, B., Faucher, J.F., Missinou, M.A., Borrmann, S., Dangelmaier, O., Horton, J., Kremsner, P.G. Lancet (2000)
- Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model. Marley, S.E., Eberhard, M.L., Steurer, F.J., Ellis, W.L., McGreevy, P.B., Ruebush, T.K. Antimicrob. Agents Chemother. (1997)
- Population pharmacokinetics of the new antimalarial agent tafenoquine in Thai soldiers. Edstein, M.D., Kocisko, D.A., Brewer, T.G., Walsh, D.S., Eamsila, C., Charles, B.G. British journal of clinical pharmacology. (2001)
- Measurement of tafenoquine (WR 238605) in human plasma and venous and capillary blood by high-pressure liquid chromatography. Kocisko, D.A., Walsh, D.S., Eamsila, C., Edstein, M.D. Therapeutic drug monitoring. (2000)